IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 114 filers reported holding IGM BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,740 | -17.7% | 9,909 | -9.1% | 0.05% | -16.7% |
| Q2 2023 | $100,570 | +43.2% | 10,896 | +113.1% | 0.06% | +53.8% |
| Q1 2023 | $70,253 | -41.6% | 5,113 | -27.8% | 0.04% | -38.1% |
| Q4 2022 | $120,397 | -27.5% | 7,078 | -3.3% | 0.06% | -4.5% |
| Q3 2022 | $166,000 | +26.7% | 7,319 | +0.7% | 0.07% | +34.7% |
| Q2 2022 | $131,000 | -10.3% | 7,267 | +32.9% | 0.05% | -24.6% |
| Q1 2022 | $146,000 | -14.1% | 5,469 | -5.5% | 0.06% | +1.6% |
| Q4 2021 | $170,000 | +16.4% | 5,787 | +161.5% | 0.06% | 0.0% |
| Q3 2021 | $146,000 | -24.7% | 2,213 | -4.9% | 0.06% | -20.0% |
| Q2 2021 | $194,000 | -26.2% | 2,328 | -32.2% | 0.08% | -27.9% |
| Q1 2021 | $263,000 | -11.7% | 3,434 | +1.8% | 0.11% | -10.5% |
| Q4 2020 | $298,000 | -18.1% | 3,374 | -31.6% | 0.12% | -35.1% |
| Q3 2020 | $364,000 | -10.8% | 4,933 | -11.8% | 0.19% | -1.0% |
| Q2 2020 | $408,000 | – | 5,592 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |